Novel lung function tests can improve phenotyping and differential therapy in COPD
F. Trinkmann (Mannheim, Germany), J. Gawlitza (Mannheim, Germany), J. Schäfer (Mannheim, Germany), M. Schroeter (Mannheim, Germany), J. Drayß (Mannheim, Germany), J. Michels (Mannheim, Germany), M. Borggrefe (Mannheim, Germany), I. Akin (Mannheim, Germany), J. Saur (Mannheim, Germany)
Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Trinkmann (Mannheim, Germany), J. Gawlitza (Mannheim, Germany), J. Schäfer (Mannheim, Germany), M. Schroeter (Mannheim, Germany), J. Drayß (Mannheim, Germany), J. Michels (Mannheim, Germany), M. Borggrefe (Mannheim, Germany), I. Akin (Mannheim, Germany), J. Saur (Mannheim, Germany). Novel lung function tests can improve phenotyping and differential therapy in COPD. 3379
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: